4.5 Article

Refining Risk for Alzheimer's Disease Among Heterozygous APOE epsilon 4 Carriers

Related references

Note: Only part of the references are listed.
Article Genetics & Heredity

Systematic comparison of family history and polygenic risk across 24 common diseases

Nina Mars et al.

Summary: This study analyzed data from the FinnGen project and found that family history and genome-wide PRS are independent and complementary measures in assessing inherited disease risk across common diseases. The study also provides a catalogue of risk estimates for family history of disease and PRSs in common diseases.

AMERICAN JOURNAL OF HUMAN GENETICS (2022)

Article Clinical Neurology

2022 Alzheimer's disease facts and figures

Joseph Gaugler et al.

Summary: This article discusses the impact of Alzheimer's disease on public health, including its incidence, prevalence, mortality and morbidity rates, healthcare costs and caregivers' burden. It also addresses the perspectives of consumers and primary care physicians on mild cognitive impairment (MCI) and the need for improved awareness, diagnosis, and treatment. The article emphasizes the increasing number of individuals living with Alzheimer's and the challenges faced by caregivers and healthcare providers, particularly during the COVID-19 pandemic.

ALZHEIMERS & DEMENTIA (2022)

Article Genetics & Heredity

The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation

Samuel A. Lambert et al.

NATURE GENETICS (2021)

Article Multidisciplinary Sciences

Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Itziar de Rojas et al.

Summary: This study identified 6 new genetic variants associated with Alzheimer's disease risk through a large-scale genetic association study. It also demonstrated the efficacy of a polygenic risk score in stratifying individuals at high risk of Alzheimer's disease, providing important data support for further research and preventive treatment of the disease.

NATURE COMMUNICATIONS (2021)

Article Clinical Neurology

Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials

Carolyn M. Langlois et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)

Article Multidisciplinary Sciences

The UK Biobank resource with deep phenotyping and genomic data

Clare Bycroft et al.

NATURE (2018)

Review Clinical Neurology

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

Chia-Chan Liu et al.

NATURE REVIEWS NEUROLOGY (2013)

Article Medicine, General & Internal

Disclosure of APOE Genotype for Risk of Alzheimer's Disease

Robert C. Green et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Psychiatry

Role of genes and environments for explaining Alzheimer disease

M Gatz et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)